![Richard S. Woodward](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard S. Woodward
Founder at Vascular Magnetics, Inc.
Network origin in Richard S. Woodward first degree
Entity | Entity type | Industry | |
---|---|---|---|
Vascular Magnetics, Inc.
![]() Vascular Magnetics, Inc. Medical DistributorsDistribution Services Vascular Magnetics, Inc. develops novel therapeutic products. Its VMI contains a magnetic targeting catheter, an apparatus that generates a uniform magnetic field around the leg, and biodegradable magnetic particles that contain a drug that blocks re-obstruction of the artery. The company was founded by Richard S. Woodward and Robert J. Levy in 2010 and is headquartered in Philadelphia, PA.
3
| Private Company | Medical Distributors | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Richard S. Woodward via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
IMMUNOME, INC. | Biotechnology | Director of Finance/CFO | |
University of Pennsylvania | College/University | Corporate Officer/Principal | |
Galera Therapeutics Australia Pty Ltd. | Director/Board Member | ||
Five Eleven Pharma, Inc. | Director of Finance/CFO | ||
Oncopia Therapeutics, Inc.
![]() Oncopia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Oncopia Therapeutics LLC engages in biotechnology research. The company was founded in 2017 and is headquartered in Malvern, PA. | Miscellaneous Commercial Services | Director of Finance/CFO | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
GALERA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Yale University | College/University | Undergraduate Degree | |
Synbody Biotechnology, Inc.
![]() Synbody Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Synbody Biotechnology, Inc. operates as a platform for the discovery and development of novel and attractive molecules. The company was founded by Paul L. Hallenbeck, Chris Diehnelt, Kevin D. Burroughs and Stephen Albert Johnston in 2010 and is headquartered in Chester Springs, PA. | Pharmaceuticals: Major | Director of Finance/CFO | |
Ascenta Therapeutics, Inc.
![]() Ascenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascenta Therapeutics, Inc. engages in the discovery and development of medicines for cancer. Its core technology consists of agents designed to re-establish the natural program of apoptosis (cell death) in abnormal cancer cells. Its has three small molecule programs against distinct apoptosis targets: Bcl-2 (AT-101 – an oral pan-Bcl2 inhibitor), IAP (AT-406 – an oral multi-IAP inhibitor) and HDM2. The company was founded by Dajun Yang, Marc E. Lippman, and Shaomeng Wang on June 5, 2006 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Director of Finance/CFO | |
PHASEBIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Garnet BioTherapeutics, Inc.
![]() Garnet BioTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Garnet BioTherapeutics, Inc. develops products that speed healing and reduce scarring after surgery or dermatologic procedures. It is a clinical stage regenerative medicine company that discovers, develops, and delivers new regenerative therapies by leveraging the intrinsic ability of adult somatic cells to repair, regenerate, and remodel tissue in acute and chronic disease settings. The firm's manufacturing and technology platform is a scalable GMP-compliant manufacturing process that can be applied to multiple cell types including adult bone marrow-derived stromal cells, smooth and skeletal muscle cells, dermal fibroblasts, chondrocytes, pre-adipocytes, and endothelial cells. The company was founded by Hubert J.P. Schoemaker on November 26, 2003 and is headquartered in Malvern, PA. | Miscellaneous Commercial Services | Director of Finance/CFO | |
Neuro Diagnostic Devices, Inc.
![]() Neuro Diagnostic Devices, Inc. Medical SpecialtiesHealth Technology Neuro Diagnostic Devices, Inc. provides medical devices. Its product ShuntCheck is an aid to the detection of flow in implanted cerebrospinal fluid (CSF) shunts. The company was founded by Samuel R. Neff and Frederick J. Fritz on May 16, 2005 and is headquartered in Princeton, NJ. | Medical Specialties | Director of Finance/CFO | |
NUPATHE INC | Medical Specialties | Director of Finance/CFO | |
The Children's Hospital of Philadelphia Foundation
![]() The Children's Hospital of Philadelphia Foundation Hospital/Nursing ManagementHealth Services The Children's Hospital of Philadelphia Foundation operates charitable organizations for children's health care. It conducts programs on patient care, research, and clinical education. The company was founded in 1855 and is headquartered in Philadelphia, PA. | Hospital/Nursing Management | Corporate Officer/Principal |
Statistics
International
United States | 18 |
Australia | 2 |
Sectoral
Health Technology | 10 |
Consumer Services | 4 |
Commercial Services | 3 |
Retail Trade | 2 |
Health Services | 2 |
Operational
Director of Finance/CFO | 13 |
Corporate Officer/Principal | 3 |
Treasurer | 2 |
Founder | 2 |
Undergraduate Degree | 1 |
Most connected contacts
Insiders | |
---|---|
Joel F. Sussman | 16 |
Robert J. Levy | 4 |
Robert Wilensky | 1 |
- Stock Market
- Insiders
- Richard S. Woodward
- Company connections